Archives
-
AO/PI Double Staining Kit: Practical Guide
2026-08-24
The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates viable, apoptotic, and necrotic populations by combining Acridine Orange with Propidium Iodide. It is suited to short, controlled endpoint measurements, but it should not be treated as a standalone confirmation of apoptosis pathways or as a validated long-term live-cell imaging method.
-
Imipramine, Autophagy, and Translational Strategy
2026-08-23
Imipramine is more than a tricyclic antidepressant: it is a research platform for connecting autophagy, apoptosis, lipid metabolism, neurobiology, and immune signaling. This thought-leadership article translates recent ceramide and fish nodavirus findings into a disciplined strategy for evaluating Imipramine in oncology, neuroscience, immunology, and host-pathogen models without overstating the evidence.
-
Thiazovivin: ROCK Inhibitor Workflow Guide
2026-08-22
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and human embryonic stem cell survival after dissociation. This guide explains practical preparation, controls, and troubleshooting while noting that exact dosing and clinical use are outside the supplied product evidence.
-
Fluconazole Research Workflows for Fungal Resistance
2026-08-22
Build more informative antifungal susceptibility and biofilm assays with Fluconazole, linking ergosterol disruption to autophagy-associated drug tolerance. This workflow emphasizes solvent control, planktonic-versus-biofilm comparisons, and strain-matched interpretation for Candida albicans research.
-
O-GlcNAcylation in Wnt-Driven Bone Formation
2026-08-21
The reference study identifies O-GlcNAcylation as a metabolic effector of Wnt-stimulated osteogenesis rather than merely a downstream marker. It links rapid and sustained Wnt signaling to GFAT1 activity, PDK1 stabilization at Ser174, aerobic glycolysis, bone formation, and fracture repair, providing a mechanistic framework for studying anabolic bone biology.
-
Trichostatin A: Linking HDAC and Ferroptosis Assays
2026-08-20
Trichostatin A (TSA) is a reversible HDAC inhibitor for studying chromatin acetylation, cancer phenotypes, and differentiation. This article develops a mechanistic assay framework that separates TSA-driven epigenetic effects from mitochondrial calcium–GPX4 control of ferroptosis.
-
AO/PI Double Staining Kit: Practical Workflow
2026-08-20
The AO/PI Double Staining Kit provides a rapid fluorescence-based screen for viable, apoptotic, and membrane-compromised cell populations in a single sample. It is useful for cell viability assay workflows and preliminary apoptosis or necrosis detection, but fluorescence classification should be validated for each cell type and should not be treated as a complete mechanistic or pathway assay.
-
Pitavastatin (NK-104): In Vitro Workflow Guide
2026-08-19
Pitavastatin (NK-104, SKU B1124) provides a defined HMG-CoA reductase perturbation for cellular and biochemical studies of cholesterol biosynthesis. This guide covers preparation, controls, quality checks, and interpretation boundaries; it is intended for research workflows and does not establish clinical or unvalidated in vivo use.
-
BPN-19186: Redox Assay Workflows
2026-08-19
BPN-19186 provides a practical chemical probe for connecting soluble epoxide hydrolase biology, lipid-metabolite balance, and Nrf2-ARE signaling in osteoclastogenesis models. This guide focuses on preparation, dose-ranging, orthogonal validation, and troubleshooting while clearly separating reference-supported findings from recommended starting conditions.
-
Early Life Adversity, Oxytocin, and Innate Fear
2026-08-18
Tan et al. show that social deprivation during a sensitive early-life window weakens looming-evoked innate defensive behavior in mice through reduced oxytocin receptor signaling in the superior colliculus. The combination of circuit mapping, receptor knockdown, and intranasal oxytocin rescue links early adversity to a defined visual threat pathway and suggests a framework for studying stress-related defensive dysfunction.
-
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody Guide
2026-08-18
Cy3 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit IgG in immunofluorescence, immunohistochemistry, immunocytochemistry, and flow cytometry workflows. It is intended for research use after assay-specific optimization, not for diagnostic applications or unvalidated live-cell use because the supplied buffer contains sodium azide.
-
AO/PI Double Staining Kit: Practical Workflow
2026-08-17
The AO/PI Double Staining Kit provides a rapid fluorescent cell viability assay that separates viable, apoptotic-like, and membrane-compromised cell populations using Acridine Orange and Propidium Iodide. It is suitable for endpoint screening and microscopy-based cell death assessment, but it should not be treated as a standalone proof of a specific apoptotic pathway or as a substitute for orthogonal validation.
-
Hyperthermia–Cisplatin Therapy Activates Caspase-8
2026-08-17
The reference study identifies caspase-8 accumulation and activation as a mechanistic link between hyperthermia–cisplatin treatment, apoptosis, and pyroptosis. Its experiments connect Cullin 3-dependent K63-linked polyubiquitination, p62 association, caspase-3 activation, and gasdermin processing, providing a framework for interpreting combination-treatment responses.
-
Calpain Inhibitor I, ALLN: Practical Protocol Guide
2026-08-16
This guide explains how Calpain Inhibitor I, ALLN can be used to investigate calpain- and cathepsin-linked proteolysis in apoptosis, inflammation, and ischemia-reperfusion workflows. It is intended for controlled scientific experiments, not clinical, diagnostic, or therapeutic use, and its multi-protease activity means it should not be interpreted as a calpain-only intervention.
-
Cisapride (R 51619): From Mechanism to Translation
2026-08-15
Cisapride is more than a serotonergic tool compound: its simultaneous activity at 5-HT4 receptors and hERG potassium channels creates a powerful bridge between mechanism-first biology and predictive cardiac safety. This thought-leadership guide shows how translational researchers can use Cisapride to connect receptor pharmacology, human iPSC-derived cardiomyocytes, deep-learning phenotyping, and decision-ready cardiac electrophysiology research.